Key Highlights
Stock peaked at $275.48, elevating market capitalization to $661 billion Yearly performance shows 53% appreciation, delivering 56.29% total return Second quarter revenue increased 6.6% reaching $25.31 billion; adjusted EPS at $2.90 Company elevated 2026 revenue forecast to approximately $101.1 billion Wall Street analysts upgraded price targets, including Guggenheim’s $287 projection On Tuesday, August 19, Johnson & Johnson reach…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.